Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
238 people get PMTI articles and Market Currents by email alert.
Get email alerts on PMTI »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 18, 2013)
-
Monday Options Brief: HPQ, EBAY & PMTIInteractive Brokers • Mon, Mar 18
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Jan 31, 2013)
-
GlobeNewswire (Jan 10, 2013)
-
GlobeNewswire (Nov 27, 2012)
-
GlobeNewswire (Nov 16, 2012)
-
GlobeNewswire (Oct 25, 2012)
To learn more about Seeking Alpha Pro, click here.
-
Monday Options Brief: HPQ, EBAY & PMTIInteractive Brokers • Mon, Mar 18
-
7 High-Growth Healthcare Small Caps Being Bought Up By InsidersKapitall • Tue, Jun 5, 2012
-
Cosmetic Laser Company Looks To Shine In The IPO MarketAsset Investing • Mon, May 21, 2012
-
Top Insider Trades: April 30, 2012InsiderInsights • Tue, May 1, 2012
-
Palomar Medical Technologies Q2 2010 Earnings Conference Call TranscriptThu, Jul 29, 2010
-
Palomar Medical Technologies Inc. Q1 2010 Earnings Call TranscriptSun, May 2, 2010
-
Palomar Medical Technologies, Inc., Q1 2009 Earnings Call TranscriptThu, Apr 30, 2009
-
Palomar Medical Technologies, Inc. Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
Palomar Medical Technologies, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 10, 2008
-
Palomar Medical Technologies, Inc. Q2 2008 Earnings Call TranscriptThu, Jul 31, 2008
-
Palomar Medical Technologies Inc. Q1 2008 Earnings Call TranscriptTue, May 13, 2008
-
Palomar Medical Technologies Q4 2007 Earnings Call TranscriptSun, Feb 10, 2008
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 18, 2013)
-
GlobeNewswire (Feb 7, 2013)
-
GlobeNewswire (Jan 31, 2013)
-
GlobeNewswire (Jan 10, 2013)
-
GlobeNewswire (Nov 27, 2012)
-
GlobeNewswire (Nov 16, 2012)
-
GlobeNewswire (Oct 25, 2012)
-
GlobeNewswire (Jul 26, 2012)
-
GlobeNewswire (May 22, 2012)
-
GlobeNewswire (Apr 26, 2012)
PMTI vs. ETF Alternatives
Company Description
Currently, there's no company description for PMTI.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 2, 8:15 AM Palomar Medical (PMTI): Q1 EPS of -$0.06. Revenue of $23.2M beats by $2.94M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, March 18, 8:16 AM Cynosure (CYNO) agrees to acquire aesthetic laser device maker Palomar Medical Technologies (PMTI +7.6%) for $294M in cash and stock, with the $13.65/share offer representing a premium of 8% on the latter's closing price on Friday. (PR) Comment! [Healthcare, M&A]
- Thursday, February 7, 8:56 AM Palomar Medical (PMTI): Q4 EPS of $0.12 beats by $0.08. Revenue of $22.9M (+1.7% Y/Y) beats by $0.2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, October 25, 2012, 9:41 AM Palomar Medical Technologies (PMTI): Q3 EPS of -$0.25 misses by $0.19. Revenue of $18.5M misses by $1M. (PR) Comment! [Earnings, Healthcare]
- Thursday, July 26, 2012, 10:44 AM Palomar Medical (PMTI): Q2 EPS of -$0.08 beats by $0.02. Revenue of $19.7M (+20.9% Y/Y) misses by $0.29M. (PR) Comment! [Earnings, Healthcare]
- Thursday, April 26, 2012, 11:21 AM Palomar Medical Technologies (PMTI): Q1 EPS of -$0.12 misses by $0.07. Revenue of $19M (+4.4% Y/Y) misses by $2M. (PR) Comment! [Earnings, Healthcare]
- Thursday, February 9, 2012, 8:21 AM Palomar Medical Technologies (PMTI): Q4 EPS of -$0.10 beats by $0.01. Revenue of $23M (+40.2% Y/Y) misses by $3M. Shares -2.1% premarket. (PR) Comment! [Earnings, Healthcare]
- Friday, September 16, 2011, 12:19 PM Palomar Medical Technologies (PMTI +4.9%) trades higher after settling its patent infringement lawsuits with Syneron Medical (ELOS +4.6%). Under the agreement, Syneron will pay $31M to Palomar for a license to patents on professional laser and lamp-based hair removal systems. Comment! [Healthcare, On the Move]
- Wednesday, February 2, 2011, 9:38 AM With Allergan (AGN) reining in expectations in its aesthetic/cosmetic businesses, that puts the spotlight on Palomar Medical (PMTI), Syneron (ELOS), Cynosure (CYNO) and Solta Medical (SLTM). As they report later this month, will these smaller aesthetics players show that Allergan's outlook is the exception, or are investors looking at a slower return to normal? Comment! [Healthcare]